DARIFENACIN CONTAINING SUSTAINED RELEASE DOSAGE FORMS FOR DELIVERY IN THE LOWER GI TRACT

摘要

The invention provides an oral tablet formulation consisting essentially of darifenacin hydrobromide in a high molecular weight hydroxypropyl methylcellulose matrix together with anhydrous dibasic calcium phosphate and magnesium stearate.